AstraZeneca rejects Pfizer's "final" bid

Share this article:

Managers from AstraZeneca rebuffed another offer to relinquish their autonomy, saying Pfizer's latest bid for the British drugmaker, a Friday night proposal valued at 69.4 billion pounds ($117 billion), was too low. The rejection of the bid, which Pfizer said was final, left the two drugmakers in a stalemate over a deal that would have created the world's largest drugmaker.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions